Veracyte, Inc. (VCYT): Price and Financial Metrics


Veracyte, Inc. (VCYT)

Today's Latest Price: $57.62 USD

1.72 (3.08%)

Updated Dec 4 4:00pm

Add VCYT to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 389 in Biotech

See all "A" rated Strong Buy stocks

VCYT Stock Summary

  • VCYT's price/sales ratio is 28.3; that's higher than the P/S ratio of 93.21% of US stocks.
  • VCYT's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of just 9.78% of US stocks.
  • Over the past twelve months, VCYT has reported earnings growth of 378.87%, putting it ahead of 96.11% of US stocks in our set.
  • If you're looking for stocks that are quantitatively similar to Veracyte Inc, a group of peers worth examining would be INSP, ATRC, EB, MTBC, and UPWK.
  • VCYT's SEC filings can be seen here. And to visit Veracyte Inc's official web site, go to www.veracyte.com.

VCYT Stock Price Chart Interactive Chart >

Price chart for VCYT

VCYT Price/Volume Stats

Current price $57.62 52-week high $58.00
Prev. close $55.90 52-week low $13.90
Day low $55.13 Volume 569,500
Day high $58.00 Avg. volume 512,555
50-day MA $42.51 Dividend yield N/A
200-day MA $31.03 Market Cap 3.34B

Veracyte, Inc. (VCYT) Company Bio


Veracyte Inc. operates as a molecular diagnostics company in the United States. It operates in the field of molecular cytology with genomic solutions that resolve diagnostic ambiguity and enable physicians to make informed treatment decisions at an early stage in patient care. The company was founded in 2006 and is based in San Francisco, California.


VCYT Latest News Stream


Event/Time News Detail
Loading, please wait...

VCYT Latest Social Stream


Loading social stream, please wait...

View Full VCYT Social Stream

Latest VCYT News From Around the Web

Below are the latest news stories about Veracyte Inc that investors may wish to consider to help them evaluate VCYT as an investment opportunity.

Veracyte to Present at Two Investor Conferences

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte to Present at Two Investor Conferences

Business Wire | September 15, 2020

Veracyte to Present at Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte to Present at Upcoming Investor Conferences

Business Wire | September 4, 2020

Veracyte Announces Pricing of Public Offering of 6,000,000 Shares of Common Stock

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT) (the “Company”) today announced the pricing of an underwritten public offering of 6,000,000 shares of its common stock at a public offering price of $30.00 per share. The gross proceeds to the Company from this offering, before deducting underwriting discounts and commissions and offering expenses payable by Veracyte, are expected to be $180.0 million. All of the shares are being offered by the Company. The offering is

Business Wire | August 4, 2020

Veracyte, Inc. (VCYT) CEO Bonnie Anderson on Q2 2020 Results - Earnings Call Transcript

Veracyte, Inc. (VCYT) Q2 2020 Earnings Conference Call July 30, 2020 16:30 ET Company Participants Tracy Morris - Vice President, Corporate Communications and Investor Relations Bonnie Anderson - Chairman and Chief Executive Officer Keith Kennedy - Chief Operating Officer and Chief Financial Officer John Hanna - Chief Commercial Officer Conference...

SA Transcripts on Seeking Alpha | August 3, 2020

Veracyte Announces Proposed Public Offering of Common Stock

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT) (the “Company”) today announced that it has commenced an underwritten public offering of 6,000,000 shares of its common stock. All of the shares are being offered by Veracyte. In addition, the Company expects to grant the underwriters a 30-day option to purchase up to 900,000 additional shares of its common stock at the public offering price, less underwriting discounts and commissions. Veracyte intends to use the net p

Business Wire | August 3, 2020

Read More 'VCYT' Stories Here

VCYT Price Returns

1-mo 43.94%
3-mo 81.59%
6-mo 121.19%
1-year 92.13%
3-year 807.40%
5-year 724.32%
YTD 106.38%
2019 121.94%
2018 92.65%
2017 -15.63%
2016 7.50%
2015 -25.47%

Continue Researching VCYT

Want to see what other sources are saying about Veracyte Inc's financials and stock price? Try the links below:

Veracyte Inc (VCYT) Stock Price | Nasdaq
Veracyte Inc (VCYT) Stock Quote, History and News - Yahoo Finance
Veracyte Inc (VCYT) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.931 seconds.